Hi Scary1,
I was diagnosed with Gleason 9 with ECE and cribriform in 2021 and was treated at UW/Fred Hutch which is a NCI and NCCN designated institution. Several weeks into proton therapy and following a CT assessment, my subsequent treatment sessions were postponed to allow for the plan to be adjusted beyond what could be accomplished by the software which facilitates minute daily adjustments. In addition to movement of vital organs on an ongoing basis, neoadjuvant ADT (with or without an ARPI) can result in changes in the prostate or tumor within the prostate , including over the short period of time between simulation and treatment, that can result in vital organs receiving higher or the tumor lower than the desired dose of radiation. I viewed the delay to rework the plan as competance and concern for the longterm outcome of my therapy. The application of ongoing advances in technology and the results of the latest studies on adaptive radiation therapy should help you achieve the best possible outcome from your treatment.

I continue to do well with no residual side effects to date and a current PSA of .07. I wish for your journey with PCa to be both effective and uneventful!

Bill